Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesTemporary CodesHCPCS hcpcs-q3014-telehealth-originating-site-facility-fee
    Ask Trek AI about this page

    HCPCS Q3014: Telehealth Originating Site Facility Fee

    Commercial payers pay $29 on average nationally for this procedure.

    HCPCS Level II code Q3014 describes the telehealth originating site facility fee charged when a patient is physically present at an originating site (such as a clinic, hospital, or other medical facility) to receive a telehealth visit; it represents a facility service associated with conducting a synchronous telemedicine encounter rather than the professional telehealth visit itself.

    For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.

    Customize your policy alerts

    Sign up for hcpcs Q3014 policy alerts

    Get alerted when payer policies referencing Q3014 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    Commercial national averages center around BUCA’s mean of $28.90 for Q3014, with notable variation across major carriers. UnitedHealth Group has the highest mean at $43.50 and a wide interquartile spread (P75 $55.30 minus P25 $26.70 = $28.60), indicating substantial price dispersion within that payer. Blue Cross Blue Shield’s mean is $27.50 with a narrower IQR (P75 $28.70 minus P25 $22.60 = $6.10), reflecting more consistency around its central tendency.

    Cigna and Aetna exhibit relatively compact spreads compared with UnitedHealth Group: Cigna’s IQR is $7.90 (P75 $29.60 minus P25 $24.70) and Aetna’s IQR is $18.50 (P75 $28.00 minus P25 $9.50). BUCA’s average at $28.90 sits near the market median cluster, while Blue Cross Blue Shield and Cigna show tighter concentration around the mid-$20s, and UnitedHealth Group shows the widest dispersion among the listed commercial payers.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 42-year-old established patient presents to a rural clinic that serves as an authorized telehealth originating site. The patient calls ahead and is registered at the clinic front desk; vital signs and a brief intake are completed by nursing. The patient is placed in a private exam room at the clinic (the originating site), and the clinic bills the telehealth originating site facility fee for use of their location and telehealth support. The patient then connects by real-time audiovisual telehealth to a remote primary care physician located at another facility for an evaluation of acute cough and nasal congestion. The remote clinician documents the encounter, provides an assessment (e.g., acute upper respiratory infection) and plan, and documents that the patient was located at the originating site during the audiovisual telehealth visit.

    The clinical workflow: patient scheduling/registration at the originating site; rooming and brief vital signs; verification of patient identity and consent for telehealth; initiation of the audiovisual connection to the distant provider; documentation by the distant provider and clinical staff; billing of the originating site facility fee using Q3014 with applicable modifiers and the appropriate ICD-10 diagnosis (for example J06.9).

    Related Diagnoses

    ICD-10 CodeDescriptionClinical Relevance
    Z71.1

    Related Modifiers

    5 rows

    ModifierDescriptionWhen to Use
    95Modifier 95 indicates that a service was provided via synchronous, real‑time audio‑video telehealth rather than in‑person. Per CMS, AAPC and professional associations, append modifier 95 to claim…- Use modifier 95 to indicate a service was furnished via synchronous, real‑time audiovisual telehealth (a live audio‑video conference between patient and provider) rather than in‑person. - Pair…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    P5Modifier P5 denotes a moribund patient who is not expected to survive without the operative procedure and is used only with anesthesia CPT codes 00100–01999. The anesthesia provider must append P5…- Use modifier P5 only when the anesthesia provider determines the patient is moribund and not expected to survive without the operation, and append it only to anesthesia CPT codes 00100–01999…
    81Modifier -81 indicates a physician served as a minimal assistant surgeon for part—not all—of an operative procedure. Use when a physician’s assisting role is limited and does not represent full…- Use CPT modifier -81 when a physician acts as a minimum assistant surgeon who assists during only part (a limited portion) of an operative procedure; append -81 to the primary surgical CPT code to…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    208D00000X
    207Q00000X
    207R00000X
    208000000X
    2084P0800X
    347B00000X
    106S00000X
    111NX0100X

    Related ICD-10-CM Codes

    5 rows

    ICD-10-CM CodeDescription
    Z71.1Person with feared health complaint in whom no diagnosis is made
    F41.9Anxiety disorder, unspecified
    Z00.00Encounter for general adult medical examination without abnormal findings
    Z00.129Encounter for routine child health examination without abnormal findings
    J06.9Acute upper respiratory infection, unspecified

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    HIV/AIDS Pharmacologic Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Testing for Diagnosis of Active or Latent TuberculosisOscar Health2026-10-01

    Related Codes

    HCPCS-LEVEL-II-Q4139-INJECTABLE-AMNIOMATRIX-BIODMATRIX-1-CC

    HCPCS Q4139: Amniomatrix or Biodmatrix, Injectable, 1 cc

    HCPCS-LEVEL-II-Q4256-AREA-BASED-PROCEDURAL-ADD-ON-PER-SQ-CM

    HCPCS Q4256: MLG-complete Skin Graft Material, Per Sq Cm

    HCPCS-LEVEL-II-Q5132-ADALIMUMAB-AFZB-ABRILADA-10MG-INJECTION

    HCPCS Level II Q5132: Injection, adalimumab-afzb (Abrilada), 10 mg

    HCPCS-Q0035-CARDIOKYMOGRAPHY-CARDIAC-MOTION-RECORDING

    HCPCS Level II Q0035: Cardiokymography

    HCPCS-Q0081-INFUSION-THERAPY-NON-CHEMOTHERAPEUTIC-PER-VISIT

    HCPCS Level II Q0081: Infusion Therapy, Non‑Chemotherapeutic, Per Visit

    HCPCS-Q0083-CHEMOTHERAPY-NON-INFUSION-ADMINISTRATION

    HCPCS Q0083: Chemotherapy Administration, Non-Infusion Methods

    HCPCS-Q0084-CHEMOTHERAPY-INFUSION-ADMINISTRATION-PER-VISIT

    HCPCS Q0084: Chemotherapy Infusion Administration, Per Visit

    HCPCS-Q0085-CHEMOTHERAPY-INFUSION-PLUS-OTHER-TECHNIQUES-PER-VISIT

    HCPCS Q0085: Chemotherapy Infusion Plus Other Technique(s), Per Visit

    HCPCS-Q0091-PAP-SMEAR-SPECIMEN-COLLECTION-TRANSPORT

    HCPCS Q0091: Screening Papanicolaou Smear Collection and Transport

    HCPCS-Q0092-PORTABLE-XRAY-EQUIPMENT-SETUP

    HCPCS Q0092: Set-up Portable X-ray Equipment

    Showing 1–10 of 629

    • More pages

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    Person with feared health complaint in whom no diagnosis is made
    Relevant when the telehealth visit addresses patient anxiety about symptoms without an identifiable medical diagnosis; supports counseling and evaluation services delivered via telehealth.
    Z00.00Encounter for general adult medical examination without abnormal findingsUsed when the telehealth encounter is for routine adult health assessment at an originating site and no abnormal findings are present.
    Z00.129Encounter for routine child health examination without abnormal findingsUsed for routine pediatric well visits conducted via telehealth from an originating site with no abnormal findings.
    F41.9Anxiety disorder, unspecifiedRelevant to telehealth psychiatric or behavioral health visits delivered remotely with the patient at an originating site.
    J06.9Acute upper respiratory infection, unspecifiedCommon acute diagnosis evaluated via telehealth from an originating site when patients present with cough, congestion, or URI symptoms.